http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2630035-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_53ea8c349a76ee077b1143f1fc519498
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-007
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007
filingDate 2016-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2017-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8de725bcd5dbd6e2f6f9511519bd2a0d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85cd0b3c5bed8a25bbe0c05105076e2e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_debff52d5a75207e65d55749274c3d8f
publicationDate 2017-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2630035-C1
titleOfInvention Method for treatment of combined pathology of early stage of primary endothelial fuchs dystrophy and cataract
abstract FIELD: medicine. n SUBSTANCE: 2.0 mm wide main operational access is made from the temporal side and one additional paracentesis at 1 or 11 hours for the right and left eyes respectively, 1.0 mm wide. Phacoemulsification is carried out with implantation of a posterior chamber hydrophobic intraocular lens (IOL) with capsular fixation. From the corneal epithelium, a circular mark is applied with a diameter of 4 mm, a cohesive viscoelastic is injected through the paracentesis into the anterior chamber, descemetorexis is made by a micro-hook on the indicated label, the monolayer of modified endothelial cells of the cornea is removed, then the viscoelastic is aspirated, the anterior chamber is reconstituted with a balanced saline solution, the paracentesis is sealed. n EFFECT: method allows to increase visual functions, eliminate the need to use donor material, reduce the duration of manipulation. n 2 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2754493-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2801865-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2801866-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2792392-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2796939-C1
priorityDate 2016-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2394532-C1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727

Total number of triples: 22.